Halozyme Therapeutics, Inc.

Ensign Peak Advisors, Inc HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

17,963

Value ($000)

1,209

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,209	0.0%	17,963	12/31/2025
2025 Q3	11/13/2025	1,527	0.0%	20,818	9/30/2025
2025 Q2	8/12/2025	1,920	0.0%	36,918	6/30/2025
2025 Q1	5/14/2025	2,723	0.0%	42,668	3/31/2025
2024 Q4	2/14/2025	2,040	0.0%	42,668	12/31/2024
2024 Q3	11/14/2024	2,442	0.0%	42,668	9/30/2024
2024 Q2	8/13/2024	2,234	0.0%	42,668	6/30/2024
2024 Q1	5/14/2024	1,736	0.0%	42,668	3/31/2024
2023 Q4	2/14/2024	12,515	0.0%	338,600	12/31/2023
2023 Q3	11/13/2023	12,935	0.0%	338,600	9/30/2023
2023 Q2	8/14/2023	12,213	0.0%	338,600	6/30/2023
2023 Q1	5/15/2023	1,712	0.0%	44,820	3/31/2023
2022 Q4	2/13/2023	2,456	0.0%	43,170	12/31/2022
2022 Q3	11/14/2022	1,683	0.0%	42,570	9/30/2022
2022 Q2	8/12/2022	1,873	0.0%	42,570	6/30/2022
2022 Q1	5/16/2022	1,840	0.0%	46,134	3/31/2022
2021 Q4	2/11/2022	1,855	0.0%	46,134	12/31/2021
2021 Q3	11/12/2021	8,260	0.0%	203,043	9/30/2021
2021 Q2	8/13/2021	6,962	0.0%	153,311	6/30/2021
2021 Q1	5/12/2021	6,392	0.0%	153,311	3/31/2021
2020 Q4	2/12/2021	6,078	0.0%	142,305	12/31/2020
2020 Q3	11/12/2020	1,383	0.0%	52,605	9/30/2020
2020 Q2	8/12/2020	239	0.0%	8,923	6/30/2020
2020 Q1	5/11/2020	161	0.0%	8,923	3/31/2020
2019 Q4	2/14/2020	316	0.0%	17,847	12/31/2019